title: [Meningitis due to Listeria monocytogenes during adalimumab therapy].
authors.forename: Cecilia
authors.initials: C
authors.lastname: Gil
authors.forename: Jesús
authors.initials: J
authors.lastname: Legido
authors.forename: Carlos
authors.initials: C
authors.lastname: Cuenca
authors.forename: Ana
authors.initials: A
authors.lastname: Santamaría
authors.forename: María Victoria
authors.initials: MV
authors.lastname: Sacristán
authors.forename: Concepción
authors.initials: C
authors.lastname: Salvatierra
authors.forename: Eugenio
authors.initials: E
authors.lastname: Fernández-Rubio
authors.forename: Julio
authors.initials: J
authors.lastname: Izquierdo
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D008584:Meningitis, Listeria / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab